Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.
Primary care consulting for GP practices & PCNs across England. Get in touch →
MHRA Class 4 Medicines Defect Notification: Mirtazapine 30mg Tablets (Cadila Pharmaceuticals) Drug alert number: EL(26)A/28 Date issued: 08 June 2026 Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery. DMRC [...]
The post MHRA Class 4 Medicines Defect Notification: Mirtazapine 30mg Tablets (Cadila Pharmaceuticals) (Crescent Pharma Limited livery) appeared first on Community Pharmacy England.
Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.